Moderna
MRNA
#1445
Rank
C$17.22 B
Marketcap
$44.54
Share price
-3.11%
Change (1 day)
-68.85%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

EPS for Moderna (MRNA)

EPS in 2023 (TTM): -$12.31

According to Moderna 's latest financial reports the company's current EPS (TTM) is -$13.08. In 2022 the company made an earnings per share (EPS) of $30.23 a decrease over its 2021 EPS that were of $43.34.

EPS history for Moderna from 2018 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$12.31-140.72%
2022$30.23-30.25%
2021$43.34-1660.82%
2020-$2.7825.16%
2019-$2.2237.04%
2018-$1.62

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$2.42-81.51%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.61-119.93%๐Ÿ‡บ๐Ÿ‡ธ USA
-$4.34-66.85%๐Ÿ‡บ๐Ÿ‡ธ USA
-$5.88-55.03%๐Ÿ‡บ๐Ÿ‡ธ USA
$5.35-140.92%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
-$2.43-81.40%๐Ÿ‡บ๐Ÿ‡ธ USA
$20.16-254.11%๐Ÿ‡บ๐Ÿ‡ธ USA